When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRLD - Prelude Therapeutics GAAP EPS of -$0.58 beats by $0.10
Prelude Therapeutics Incorporated
2023-05-08 08:43:57 ET
Prelude Therapeutics press release ( NASDAQ: PRLD ): Q1 GAAP EPS of -$0.58 beats by $0.10 .
Cash, cash equivalents, and marketable securities as of March 31, 2023, were $172.3 million. Prelude anticipates that its existing cash, cash equivalents and marketable securities will fund the Company’s operations into the fourth quarter of 2024.